Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors (Q40589346)

21 September 2017

title

Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors (English)

1 reference

21 September 2017

author

Benita Katzenellenbogen

7

object named as

Benita S Katzenellenbogen

1 reference

21 September 2017

8

Geoffrey L Greene

1 reference

21 September 2017

Kendall W Nettles

1

1 reference

21 September 2017

Jun Sun

2

1 reference

21 September 2017

James T Radek

3

1 reference

21 September 2017

Shubin Sheng

4

1 reference

21 September 2017

Alice L Rodriguez

5

1 reference

21 September 2017

John A Katzenellenbogen

6

1 reference

21 September 2017

publication date

1 February 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

13

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

317-327

1 reference

Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Two distinct actions of retinoid-receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Structure and specificity of nuclear receptor-coactivator interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Unique response pathways are established by allosteric interactions among nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Co-regulator recruitment and the mechanism of retinoic acid receptor synergy

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Activation of specific RXR heterodimers by an antagonist of RXR homodimers

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

The phantom ligand effect: allosteric control of transcription by the retinoid X receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Point mutations and sequence variability in proteins: redistributions of preexisting populations.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Binding of ligands and activation of transcription by nuclear receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

DNA shuffling method for generating estrogen receptor alpha and beta chimeras in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Differential SERM effects on corepressor binding dictate ERalpha activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2804%2900054-1

7 January 2021

10.1016/S1097-2765(04)00054-1

Identifiers

DOI

1 reference

21 September 2017

1 reference